BPC-157 is a synthetic 15-amino acid peptide derived from a protein found in gastric juice
Shingu M, Oribe M, Todoroki T, Tatsukawa K, Tomo-oka K, Yasuda M, et al
The standard treatment includes the use of antiviral treatment (interferon-alfa with ribavirin)
This product is not a drug, is not approved by Health Canada for human or veterinary use, and must under no circumstances be administered to humans or animals
It catalyzes the reduction of glutathione from the oxidized form of GS-SG, and all other enzymes of the glutathione system use it: 2 NADP + GS-SG 2 NADP + 2 GSH The reduction of oxidized glutathione is carried out with the participation of NADP + reduction systems on the pentose phosphate pathway of glucose-6-phosphate oxidation ("Embden-Meyerhoff shunt"): NADP + + G-6-P NADP + + + 6 phosphogluconate Glutathione transferase catalyzes the reaction: RX + GSH = HX + GS-SG Some forms of glutathione transferases, like glutathione peroxidases, are capable of reducing lipid hydroperoxides to hydroxy acids (LOH) [12]